Bioceltix SA (BCX) Stock Statistics & Valuation Metrics
Total Valuation
Bioceltix SA has a market cap or net worth of PLN 387.26M. The enterprise value is PLN 445.67M.
- Market Cap
- PLN 387.26M
- Enterprise Value
- PLN 445.67M
Share Statistics
Bioceltix SA has 5,532,253 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,532,253
- Owned by Insiders
- ―
- Owned by Institutions
- 0.05%
Financial Efficiency
Bioceltix SA’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.48%.
- Return on Equity (ROE)
- -0.21
- Return on Assets (ROA)
- -0.20
- Return on Invested Capital (ROIC)
- -23.48%
- Return on Capital Employed (ROCE)
- -0.24
- Revenue Per Employee
- 0
- Profits Per Employee
- -309.37K
- Employee Count
- 49
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bioceltix SA is -20.11. Bioceltix SA’s PEG ratio is 1.18.
- PE Ratio
- -20.11
- PS Ratio
- 0.00
- PB Ratio
- 6.19
- Price to FCF
- -17.31
- Price to Operating Cash Flow
- -21.16
- PEG Ratio
- 1.18
Income Statement
In the last 12 months, Bioceltix SA had revenue of 0 and earned -15.16M in profits. Earnings per share was -3.03.
- Revenue
- 0
- Gross Profit
- -680.06K
- Operating Income
- -17.32M
- Pretax Income
- -15.17M
- Net Income
- -15.16M
- EBITDA
- -16.64M
- Earnings Per Share (EPS)
- -3.03
Cash Flow
In the last 12 months, operating cash flow was -18.30M and capital expenditures -4.06M, giving a free cash flow of -22.37M billion.
- Operating Cash Flow
- -18.30M
- Free Cash Flow
- -22.37M
- Free Cash Flow per Share
- -4.04
Dividends & Yields
Bioceltix SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.78%
- Earnings Yield
- -4.78%
Stock Price Statistics
- Beta
- 0.10
- 52-Week Price Change
- -29.29%
- 50-Day Moving Average
- 73.51
- 200-Day Moving Average
- 81.58
- Relative Strength Index (RSI)
- 49.98
- Average Volume (3m)
- 7,769
Important Dates
Bioceltix SA upcoming earnings date is Nov 27, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 23, 2026
- Next Earnings Date
- Nov 27, 2026
- Ex-Dividend Date
- ―
Financial Position
Bioceltix SA as a current ratio of 32.51, with Debt / Equity ratio of 0.43%
- Current Ratio
- 32.51
- Quick Ratio
- 32.51
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 4.09
- Interest Coverage Ratio
- -82.90
Taxes
In the past 12 months, Bioceltix SA has paid -15.38K in taxes.
- Income Tax
- -15.38K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bioceltix SA EV to EBITDA ratio is -16.47, with an EV/FCF ratio of -14.78.
- EV to Sales
- 0.00
- EV to EBITDA
- -16.47
- EV to Free Cash Flow
- -14.78
- EV to Operating Cash Flow
- -18.06
Balance Sheet
Bioceltix SA has PLN 56.83M in cash and marketable securities with PLN 171.41K in debt, giving a net cash position of PLN 56.66M billion.
- Cash & Marketable Securities
- PLN 56.83M
- Total Debt
- PLN 171.41K
- Net Cash
- PLN 56.66M
- Net Cash Per Share
- PLN 10.24
- Tangible Book Value Per Share
- PLN 11.30
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Bioceltix SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -18.83%
